355 related articles for article (PubMed ID: 22031347)
1. Development of a framework to define the functional goals and outcomes of botulinum toxin A spasticity treatment relevant to the child and family living with cerebral palsy using the International Classification of Functioning, Disability and Health for Children and Youth.
Preston N; Clarke M; Bhakta B
J Rehabil Med; 2011 Nov; 43(11):1010-5. PubMed ID: 22031347
[TBL] [Abstract][Full Text] [Related]
2. Development of an inventory of goals using the International Classification of Functioning, Disability and Health in a population of non-ambulatory children and adolescents with cerebral palsy treated with botulinum toxin A.
Nguyen L; Mesterman R; Gorter JW
BMC Pediatr; 2018 Jan; 18(1):1. PubMed ID: 29301539
[TBL] [Abstract][Full Text] [Related]
3. Use of botulinum toxin in the treatment of ankle plantar flexor spasticity in children with cerebral palsy.
Mirska A; Cybula K; Okurowska-Zawada B; Kułak W; Dmitruk E; Okulczyk K; Kalinowska AK
J Pediatr Orthop B; 2014 Nov; 23(6):517-22. PubMed ID: 25171568
[TBL] [Abstract][Full Text] [Related]
4. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin for the treatment of spasticity in children: attainment of treatment goals.
Weigl DM; Arbel N; Katz K; Becker T; Bar-On E
J Pediatr Orthop B; 2007 Jul; 16(4):293-6. PubMed ID: 17527109
[TBL] [Abstract][Full Text] [Related]
6. Functional outcomes of multilevel botulinum toxin and comprehensive rehabilitation in cerebral palsy.
Balbaloglu O; Basaran A; Ayoglu H
J Child Neurol; 2011 Apr; 26(4):482-7. PubMed ID: 21270468
[TBL] [Abstract][Full Text] [Related]
7. The role of botulinum toxin in the treatment of lower limb spasticity in children with cerebral palsy--a pilot study.
Zelnik N; Giladi N; Goikhman I; Keren G; Moris R; Honigman S
Isr J Med Sci; 1997 Feb; 33(2):129-33. PubMed ID: 9254875
[TBL] [Abstract][Full Text] [Related]
8. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
[TBL] [Abstract][Full Text] [Related]
9. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
[TBL] [Abstract][Full Text] [Related]
10. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
[TBL] [Abstract][Full Text] [Related]
11. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
Chaléat-Valayer E; Parratte B; Colin C; Denis A; Oudin S; Bérard C; Bernard JC; Bourg V; Deleplanque B; Dulieu I; Evrard P; Filipetti P; Flurin V; Gallien P; Héron-Long B; Hodgkinson I; Husson I; Jaisson-Hot I; Maupas E; Meurin F; Monnier G; Pérennou D; Pialoux B; Quentin V; Moreau MS; Schneider M; Yelnik A; Marque P
Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type A in children and adolescents with severe cerebral palsy: a retrospective chart review.
Mesterman R; Gorter JW; Harvey A; Lockhart J; McEwen-Hill J; Margallo K; Goldie N
J Child Neurol; 2014 Feb; 29(2):210-3. PubMed ID: 23965398
[TBL] [Abstract][Full Text] [Related]
13. No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy.
Alhusaini AA; Crosbie J; Shepherd RB; Dean CM; Scheinberg A
Dev Med Child Neurol; 2011 Jun; 53(6):553-8. PubMed ID: 21574991
[TBL] [Abstract][Full Text] [Related]
14. Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: gait analysis in 49 patients.
Papadonikolakis AS; Vekris MD; Korompilias AV; Kostas JP; Ristanis SE; Soucacos PN
Acta Orthop Scand; 2003 Dec; 74(6):749-55. PubMed ID: 14763710
[TBL] [Abstract][Full Text] [Related]
15. Effects of different dilutions of botulinum toxin type A treatment for children with cerebral palsy with spastic ankle plantarflexor: a randomized controlled trial.
Lee JH; Sung IY; Yoo JY; Park EH; Park SR
J Rehabil Med; 2009 Sep; 41(9):740-5. PubMed ID: 19774308
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
Kaishou Xu ; Tiebin Yan ; Jianning Mai
Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy.
Mirska A; Kułak W; Okurowska-Zawada B; Dmitruk E
Childs Nerv Syst; 2019 Jan; 35(1):141-147. PubMed ID: 30058050
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of spasticity in cerebral palsy with botulinum toxin].
Calderón-González R; Calderón-Sepúlveda RF
Rev Neurol; 2002 Jan 1-15; 34(1):52-9. PubMed ID: 11988892
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
Read FA; Boyd RN; Barber LA
Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
